Recent advances in the management of Myelodysplastic syndromes

Mostafa Kamal Helmi El-Razzaz;

Abstract


Myelodysplastic syndromes (MDS) are a heterogeneous group of acquired clonal bone marrow disorders characterized by varying degrees of pancytopenia, morphological and functional abnormalities of hematopoietic cells, and an increased risk of transformation


Other data

Title Recent advances in the management of Myelodysplastic syndromes
Other Titles الجديد فى تشخيص وعلاج متلازمات سوء النمو النخاعى
Authors Mostafa Kamal Helmi El-Razzaz
Keywords Recent advances in the management of Myelodysplastic syndromes
Issue Date 2009
Description 
Myelodysplastic syndromes (MDS) are a heterogeneous group of acquired clonal bone marrow disorders characterized by varying degrees of pancytopenia, morphological and functional abnormalities of hematopoietic cells, and an increased risk of transformation

Attached Files

File SizeFormat
Binder1.pdf866.26 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 4 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.